ブログ

OSHA Commentary on its position on Post-Incident Drug Testing in its Tracking of Workplace Injuries and Illnesses Final Rule

In OSHA’s Tracking of Workplace Injuries and Illnesses Final Rule published in the Federal Register Vol. 84, No. 17 on January 25, 2019 OSHA commented on the post-incident drug testing in the Rule’s Section I, Background Information as follows at page 383 second column,  noting

“While not the focus of this particular rulemaking, that memorandum accurately reflects OSHA’s position and addresses the commenters’ concerns.” https://www.govinfo.gov/content/pkg/FR-2019-01-25/pdf/2019-00101.pdf

From the Rule’s Section I Background Information:

In response to concerns about the application of the 2016 final rule to employee drug testing and incident based incentive programs, OSHA notes that the employee protection provisions promulgated by that final rule and codified at 29 CFR 1904.35 neither ban drug testing employees involved in workplace injury or illnesses, nor prohibit incident-based incentive programs. Rather, § 1904.35(b)(1)(iv) merely prohibits employers from implementing these programs to penalize workers ‘‘for reporting a work related injury or illness.’’ Id. (emphasis added). On October 11, 2018, OSHA issued a memorandum that explained this regulatory text and OSHA’s position on workplace incentive programs and post-incident drug testing. See U.S. Dep’t of Labor, Clarification of OSHA’s Position on Workplace Safety Incentive Programs and Post-Incident Drug Testing Under 29 CFR§ 1904.35(b)(1)(iv) (Oct. 11, 2018). That memorandum—which referred to the2016 final rule and its preamble—reiterated the rule’s limited scope and expressed how it ‘‘does not prohibit workplace safety incentive programs or post-incident drug testing.’’ Id. To the extent the 2016 preamble suggested otherwise, it has been superseded. While not the focus of this particular rulemaking, that memorandum accurately reflects OSHA’s position and addresses the commenters’ concerns.

https://www.govinfo.gov/content/pkg/FR-2019-01-25/pdf/2019-00101.pdf page 383.

 

The Department of Labor’s referenced Clarification of OSHA’s Position on Workplace Safety Incentive Programs and Post-Incident Drug Testing Under 29 CFR§ 1904.35(b)(1)(iv) (Oct. 11, 2018) can be reviewed at:  https://www.osha.gov/laws-regs/standardinterpretations/2018-10-11

本情報は、情報共有のみを目的として提供されます。 First Advantageは法律を専門とする企業ではなく、本情報は法律上のアドバイスではなく、アドバイスを意図するものでもありません。本情報は最新の情報に更新されていない可能性がございます。

本情報の読者は、ご自身の特定の状況に応じて、ご自身の法律専門家にご相談ください。いかなる人も、本情報に基づいて行動したり、行動を控えるべきではありません。ご自身の弁護士、または法的アドバイザーのみが、こちらに含まれる情報とその解釈があなたの特定の状況に適用可能または適切であることを保証することができます。

本情報の利用及びアクセスによって、本プレゼンテーションの読者、またはユーザーとFirst Advantageとの間に弁護士-クライアント関係を創出することはありません。